ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 78 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,157 | +290.7% | 10,458 | +363.2% | 0.00% | – |
| Q2 2023 | $2,088 | +59.6% | 2,258 | +88.2% | 0.00% | – |
| Q1 2023 | $1,308 | -34.6% | 1,200 | 0.0% | 0.00% | – |
| Q4 2022 | $2,000 | +100.0% | 1,200 | -4.0% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 1,250 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 1,250 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -60.0% | 1,250 | 0.0% | 0.00% | – |
| Q4 2021 | $5,000 | 0.0% | 1,250 | +19.0% | 0.00% | – |
| Q3 2021 | $5,000 | – | 1,050 | +2000.0% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 50 | -99.6% | 0.00% | – |
| Q3 2020 | $101,000 | +3266.7% | 12,676 | +1167.6% | 0.00% | – |
| Q1 2020 | $3,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Matrix Capital Management Company, LP | 38,974,185 | $166,030,000 | 1.81% |
| Endurant Capital Management LP | 1,539,435 | $6,558,000 | 1.80% |
| NEA Management Company, LLC | 17,082,611 | $72,772,000 | 0.95% |
| PFM Health Sciences, LP | 3,627,900 | $15,455,000 | 0.48% |
| GSA CAPITAL PARTNERS LLP | 513,388 | $2,187,000 | 0.25% |
| Baker Brothers Advisors | 9,830,877 | $41,880,000 | 0.18% |
| Avoro Capital Advisors LLC | 2,024,400 | $8,624,000 | 0.15% |
| Vigilare Wealth Management | 54,250 | $231,000 | 0.14% |
| AlphaCentric Advisors LLC | 120,000 | $511,000 | 0.14% |
| Rock Springs Capital Management LP | 1,545,000 | $6,582,000 | 0.13% |